Dr Honavar Becomes the First Indian Ophthalmologist to Receive the Highest Award of Royal College of Ophthalmologists, UK indiaeducationdiary.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiaeducationdiary.in Daily Mail and Mail on Sunday newspapers.
NEW DELHI: Bhabha Atomic Research Centre (BARC)-developed eye cancer therapy has been successfully used for the first time for the treatment of patients with ocular tumours in AIIMS-Delhi and the results of using Ruthenium 106 plaque for treatment of a patient with choroidal hemangioma (benign tumour in blood vessels) have been found to be satisfactory.
Union minister of state for atomic energy Jitendra Singh, who facilitated the collaboration between the Department of Atomic Energy (DAE) and Dr Rajendra Prasad Centre for Ophthalmic Sciences, AIIMS, Delhi, informed about the breakthrough and lauded the BARC for developing the “simple and cost-effective therapy” for eye cancer patients.
BARC develops indigenous Ruthenium 106 Plaque to treat eye cancer
BARC develops indigenous Ruthenium 106 Plaque to treat eye cancer
29 December 2020 | News The handling of plaque is very convenient for the surgeon and it has been acknowledged to be at par with the international standards
Source credit: Shutterstock
Dr Jitendra Singh, Union Minister of State (Independent Charge) Development of North Eastern Region (DoNER), MoS PMO, Personnel, Public Grievances, Pensions, Atomic Energy and Space has lauded the Bhabha Atomic Research Centre (BARC) Mumbai for developing Eye Cancer therapy in the form of the first indigenous Ruthenium 106 Plaque for treatment of Ocular Tumours. The handling of plaque is very convenient for the surgeon and it has been acknowledged to be at par with the international standards.